Global Newborn Screening Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Newborn Screening Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies), Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types), End User (Hospitals, Diagnostic Centers, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Newborn Screening Market was valued at USD 926.9 million in 2023 and is expected to reach USD 1,754.2 million by 2031 while growing at a CAGR of 8.3% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global newborn screening market growth. Newborn screening, a public health initiative, swiftly identifies various genetic, metabolic, hormonal, and functional disorders in newborns to prevent potential health complications, developmental delays, or mortality. This involves collecting a small blood sample from the baby's heel within the first 24 to 48 hours after birth.
The newborn screening market is propelled by rising awareness, government initiatives, and technological advancements in screening methods like tandem mass spectrometry (MS/MS), next-generation sequencing (NGS), and molecular diagnostics. Nonetheless, cost constraints and reimbursement challenges impede its growth.
Furthermore, the global newborn screening industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Newborn Screening Market is segmented among Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies, based on Technology. In 2023, Tandem Mass Spectrometry accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Test Type Analysis
The Global Newborn Screening Market is segmented among Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types, based on Test Type. In 2023, Dry Blood Spot Test accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Newborn Screening Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Bio-Rad Laboratories, Agilent Technologies, Covidien plc, Masimo, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc, and AB SCIEX.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Newborn Screening Market Dynamics
Drivers
Restraints
Opportunity
4. Global Newborn Screening Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Newborn Screening Market Segmentation, By Technology
Global Newborn Screening Market Share Analysis, By Technology
Global Newborn Screening Market Growth Analysis, By Technology
Global Newborn Screening Market Trends, By Technology
o Tandem Mass Spectrometry
o Pulse Oximetry
o Enzyme Based Assays
o DNA Assays
o Other Technologies
6. Global Newborn Screening Market Segmentation, By Test Type
Global Newborn Screening Market Share Analysis, By Test Type
Global Newborn Screening Market Growth Analysis, By Test Type
Global Newborn Screening Market Trends, By Test Type
o Dry Blood Spot Test
o CCHD
o Hearing Screen
7. Global Newborn Screening Market Segmentation, By End User
Global Newborn Screening Market Share Analysis, By End User
Global Newborn Screening Market Growth Analysis, By End User
Global Newborn Screening Market Trends, By End User
o Instruments
o Reagents
8. Global Newborn Screening Market Segmentation, By Region
Global Newborn Screening Market Share Analysis, By Region
Global Newborn Screening Market Growth Analysis, By Region
Global Newborn Screening Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Bio-Rad Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Agilent Technologies
Covidien plc
Masimo
Waters Corporation
Natus Medical
Trivitron Healthcare
GE Lifesciences
PerkinElmer Inc
AB SCIEX
*Similar analysis will be provided for each company listed above.
